Bluestone Jeffrey 4
4 · GILEAD SCIENCES, INC. · Filed Dec 1, 2025
Insider Transaction Report
Form 4
Bluestone Jeffrey
Director
Transactions
- Exercise/Conversion
Common Stock
2025-11-28$64.92/sh+5,000$324,600→ 13,920 total - Sale
Common Stock
2025-11-28$125.08/sh−5,000$625,400→ 8,920 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2025-11-28−5,000→ 7,648 totalExercise: $64.92Exp: 2034-05-08→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]100% of the shares subject to the stock option vested immediately upon the grant date of May 8, 2024.